Archive for REGENOCYTE

STEM CELL VICTORIES – Dilated Cardio-Myopathy

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES with tags , , , , , , , , , on March 1, 2009 by David Granovsky

cardiomyopathy

cardiomyopathy

Leonard Narracci – Dilated Cardio-Myopathy

My name is Leonard Narracci, and I live in Venice, Florida. Three years ago, I was diagnosed with Dilated Cardio-Myopathy. I was always tired, listless, and completely lethargic. I underwent all the traditional cardiac testing, and the bottom line was that I would be on medication, Toprol and Atacand, Ace inhibitors and Beta Blockers, to maintain the status quo, but there was little hope of improving my cardiac condition.

Discovering Dr. Zannos Grekos

After 3 years of living like this, I told my wife that I could not continue to live like this, but that I had to search for a more viable option. I began my research to find a “better way”. I found Regenocyte and Dr. Zannos Grekos, right here in my backyard in Bonita Springs, Florida. I researched his Stem Cell Therapy treatment intensely. Then, I attended a seminar of his, which confirmed the action that I had to take to repair my heart. I made an appointment with him and underwent all the necessary testing to determine if I was a viable candidate. Fortunately, I was! I expressed the desire to have the treatment, and his office set everything in motion.

Treatment Abstract

The entire Regenocyte experience was nothing short of perfection, beginning with his very capable and competent assistant, Nancy Trombino. Nancy made all the necessary arrangements and reservations and provided me with an itinerary that explicitly told me where and when I had to be all at times during the treatment. I had 8 ounces of blood drawn, and a courier was waiting to transport the blood to Miami Airport to be flown to a bio-tech lab in Israel. My stem cells were extracted, genetically engineered for heart repair, and then replicated to 143,000,000 stem cells.

Experience as a patient

On October 7, 2008, my wife, my friend, and I left Miami Airport for the Dominican Republic. As soon as we deplaned, we were met by two Regenocyte agents, who were wonderful. They transported us to the Marriott Hotel, which was charming and very comfortable. The staff there made every effort to provide us with all that we needed. The Regenocyte agents catered to our every want and need, even providing me with a cell phone. All I had to do was press a single number and I could make contact with an agent at any time of the day or night.

Treatment Procedure

On October 8th. Dr. Grekos had also flown in to the Dominican republic to perform the procedure. The agent took us to the hospital where I was prepped for the procedure and then taken to the Catheterization Lab for the procedure. The procedure takes between an hour and an hour and a half. The procedure consisted of 2 parts. In the first, my arteries in my heart were each shut off for 3 minutes, while the stem cells were infused. In the second part, the stem cells were directly injected into the diseased walls of my heart.

Treatment Experience

I felt absolutely nothing, and was totally fascinated watching the entire procedure on the monitor. During the entire treatment, Dr. Grekos would check on me, and tell me that everything was proceeding perfectly.Upon completion of the treatment, I was taken to an ICU room to be monitored overnight.

Post treatment

The next morning, October 9th., I was discharged, and the agents took me back to the hotel to relax for the rest of the day, per Dr. Grekos’ orders. The next morning, October 10th. The Regenocyte agents took us to the airport, and before we knew it, we were back in Miami, and my wife and I were on our way back home to Venice, Florida. For the next few days, I just took it easy and rested.

7 Days Later -Improvement

Exactly 7 days after the treatment I was feeling a renewed engergy and sense of well-being that I had not experienced in three years.

2 Weeks Later -Ejection Fraction up from 20 to 28

Two weeks after the treatment, I had a follow-up appointment with Dr. Grekos. He was much more than pleased with the results he found. He did an Echogram, and the results were nothing short of remarkable. After only two weeks he found that my heart apex was normal, my heart had decreased in size and my ejection fraction had risen from 20 to 28. On November 25th.

7 Weeks Later – Ejection Fraction up from 28 – 33

I went back to Doctor Grekos’ office for more testing, 7 weeks after treatment. The Echogram showed the walls of my heart thickening, indicating that the stem cells were regenerating healthy heart muscle that previously was non-functional and not contracting. It was now contracting strongly, evidenced by the fact that my ejection fraction was now up to 33. I guess these results say it all, and I am looking forward to the progression of these results over the next several months.

3 Months Later – Ejection Fraction up from 33 – 45

The middle of January, I will have more heart tests for the 3 month follow-up and then again at 6 months and at 9 months. January 23rd. I had my important 3 month follow-up appointment with Dr. Grekos. The week before, I had the testing: EKG, ICG, Nuclear Stress Test, and Muga Scan. The tests revealed that the dimensions of my enlarged heart had decreased and that my Ejection Fraction had now increased from 33 to 45. This is especially significant in light of the fact that I am only 10 points away from 55 which is a normal Ejection Fraction.

My Opinion of Dr Grekkos

Other than Dr. Grekos, there is no other invasive cardiologist in the world who has done more to advance and effectively apply the principles of Adult Stem Cell Therapy. Even the typically sceptical medical community is beginning to acknowlege the efficacy of the treatment and the expertise of Dr. Grekos. I cannot help but show my enthusiasm for a procedure and a doctor who has given back to me a quality of life that I never thought I would see again.

My hope and prayer

My hope and prayer is that the medical community and the FDA will very soon come to the realization of the significance of this treatment and provide the necessary approval, so that patients do not have to continue to go out of the country.

Stem Cells: Politics, processes and potential : Neapolitan : Naples Daily News

Posted in ALL ARTICLES, STEM CELLS IN THE NEWS with tags , , , , , , , , , , , , , on February 18, 2009 by David Granovsky
science-ethics-politics

science-ethics-politics

Stem Cells: Politics, processes and potential

BETH KALVIN, Director of Communications/Regenocyte Therapeutic -6:00 p.m., Monday, February 16, 2009

After the inauguration of President Barack Obama, those on both sides of the stem cell research debate are expecting President Bush’s curb on federal funding to be lifted.

Geron Corp. announced it had received approval from the U.S. Food and Drug Administration for the world’s first study of a human embryonic stem cell therapy, testing its product on patients with acute spinal cord injury. The company reported it has spent “at least $100 million on embryonic stem cell research” and it isn’t alone in its quest.

So while the majority of public and private dollars are poured into embryonic stem cell research, advocates of other stem cell therapies are lobbying for a share, with strong clinical results behind them. The chasm between types of stem cells is nearly as wide as the divergence of opinion on the political and ethical issues. The impacts of a legislative change may depend heavily on the current administration’s — and the public’s — understanding of the science that is now becoming medicine.

Embryonic stem cells can develop into any cell of the body, and scientists have long hoped to harness them for creating replacement tissues to treat a variety of diseases. But to date no successful human treatment has been found using embryonic cells. The treatment research has been controversial because human embryos must be destroyed. Plus, the pluripotent quality of the cells poses many risks for adverse effects.

Cord blood cells, when saved or “banked,” can address many serious diseases and are considered much safer than embryonic cells because they are autologous, meaning cells belonging to the patient, and the body will not reject its own cells. However, the availability of cord blood cells is limited and tissue matching is required.

Adult stem cells circulate throughout our bodies and act as natural healers. They have vast potential and limitless capabilities. As a treatment option, they are considered extremely safe because they are also autologous, coming directly from the patient’s own blood, bone marrow, skin or fat. For more than 40 years, adult stem cells have been used to treat cancers, particularly leukemia.

Recent advancements in adult stem cell therapy have meant thousands of patients around the world have been helped for serious health conditions outside of cancer. The process begins with drawing of the patient’s blood or marrow. The stem cells are then extracted in a biotechnology lab.

Bio-agents like growth factors are applied to expand the stem cell population and direct the cells to repair and regenerate specific tissue damaged by disease.

Just a few days later, the newly engineered cells are reintroduced to the patient’s body by injection or through a catheter into the blood vessels. The patient generally returns home in one to two days and the regeneration process within their body begins.

Southwest Florida-based Regenocyte Therapeutic released data last month to the World Congress on Regenerative Biomedical Technologies on patients treated for heart, vascular and pulmonary diseases that were studied through one year after Adult Stem Cell Therapy. The report showed measurable improvement in congestive heart failure class status, breathing and kidney function. PET scans confirmed that adult stem cells have the ability to engraft themselves into areas damaged by heart attacks and turn into viable, new heart muscle.

Dr. Héctor José Rosario, professor of cardiology at Pontifical Catholic University School of Medicine and director of cardiovascular therapy for Regenocyte’s Dominican division, stated in the report that “three months after treatment, cardiac nuclear scans of the areas treated reveal reversal of damage.” The company’s medical adviser, Athina Kyritsis, M.D., explains: “Regenocyte has been able to take patients off the transplant list, and we have been doing it consistently.”

Dr. Kyritsis explains the potential to revolutionize medicine is great: “I believe we have only begun to discover what adult stem cells can accomplish in altering the course of diseases currently believed to be untreatable, with not only better clinical results than embryonic cell studies offer, but a long-term financial savings to society.”

Regenocyte Therapeutic is using adult stem cell therapy to treat congestive heart failure, cardiomyopathy, peripheral artery disease, coronary artery disease, kidney disease, ischemic heart disease, pulmonary diseases and hypertension, and early senile dementia. The U.S. Clinical Center with complete diagnostic capabilities and its own catheterization lab is located in Bonita Springs, where there are 39 employees and associates. Physicians, treatment and laboratory facilities are also located in Israel and the Dominican Republic.

An educational seminar, “Turning Stem Cells into Medicine: Current Clinical Applications and Case Studies,’’ will be held Saturday, March 7, at 1 p.m. at the Collier Regional Library headquarters on Orange Blossom Drive in North Naples. The program is free and open to the public, featuring Zannos G. Grekos, MD, who is director of Cardiology & Vascular Disease for Regenocyte Therapeutic. Dr. Grekos also is associate clinical professor of cardiology for Nova Southeastern University. In 2007, he was invited to brief the U.S. Senate Health Advisory Committee on the current state of stem cell research and has since lectured at international physician conferences from Washington to Dubai, U.A.E.

via Stem Cells: Politics, processes and potential : Neapolitan : Naples Daily News.

STEM CELL TREATMENTS FOR HEART (CARDIOVASCULAR DISEASE)

Posted in ALL ARTICLES, SCIENCE & REFERENCE, VICTORIES & SUCCESS STORIES with tags , , , , , , , , , , , , , , , on February 9, 2009 by David Granovsky

PRE-VALENTINES DAY SPECIAL

PRE-VALENTINES DAY SPECIAL

STEM CELL TREATMENT CENTERS FOR HEART (CARDIOVASCULAR DISEASE)

1 Bangkok Heart Hospital – Thailand – karom@bangkokheart.com

2 Dr. Roberto Fernandez Vina – El Salvador – dorauno44@hotmail.com

3 Regenocyte – Dominican Republic – pshwartz@regenocyte.com

. . . .

Source: http://repairstemcells.org/TreatmentDetail.php?keyword=Heart+(Cardiovascular)+Diseases

Other Diseases: http://repairstemcells.org/DiseaseTreated.php

Add to FacebookAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to Ma.gnoliaAdd to TechnoratiAdd to FurlAdd to Newsvine